stockportfolio.pro
Stocks / DBD vs RUN
DBD vs RUN
Diebold Nixdorf, Incorporated and Sunrun Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Technology.
| Diebold Nixdorf, Incorporated (DBD) | Sunrun Inc. (RUN) | |
|---|---|---|
| Market cap | $2.8B | $2.8B |
| Revenue (latest FY) | $3.81B | $2.96B |
| Net income (latest FY) | $94.60M | $449.95M |
| Revenue growth (5y CAGR) | -0.5% | 26.2% |
| Net margin | 2.5% | 15.2% |
| Return on equity | 8.6% | 14.4% |
| P/E ratio | 27.9 | 5.5 |
| Dividend yield | — | — |
| Profitable years (of last 10) | 1 | 6 |
| Positive free cash flow | — | — |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open DBD — free Open RUN — freeFrequently asked questions
Which is bigger, DBD or RUN?
Sunrun Inc. is larger by market capitalization — $2.8B versus $2.8B.
Which grows faster, DBD or RUN?
Over the last five fiscal years, Sunrun Inc. grew revenue faster — 26.2%/yr versus -0.5%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.